abstract |
The present invention relates to a compound of formula I, wherein A and Cy have one of the meanings as indicated in this specification, and its use as an inhibitor of cathepsin C; pharmaceutical compositions containing it and its use as a treatment for and/or methods of agents for the prevention of diseases associated with dipeptidyl peptidase I activity, such as respiratory diseases. |